DANIEL W. THOMAS

机构：Royal Adelaide Hospital, South Australian Health and Medical Research Institute, Central Adelaide Local Health Network, Adelaide University, The University of Adelaide · ORCID：0000-0002-0837-1231

发表论文 351 篇 · 总被引 7774 次 · h-index 39

代表论文

• Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations (2025 · Blood Advances · 被引 20)
• Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort (2025 · Blood Cancer Journal · 被引 13)
• The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities (2025 · Immunological Reviews · 被引 8)
• Durable Responses Observed in Chronic Myelomonocytic Leukemia Treated with Lenzilumab and Azacitidine (2024 · Blood · 被引 4)
• TP53-Mutated Therapy-Related Myeloid Neoplasms Are Associated with a Long Latency and Are More Prevalent in Patients with Primary Hematological Cancers Compared to Solid Tumors (2024 · Blood · 被引 3)
• CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting (2024 · PLoS ONE · 被引 3)